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Abstract 
 
The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was developed to assess 
cognitive and behavioural changes common in Amyotrophic Lateral Sclerosis and other 
diseases affecting motor functions. It focuses on domains typically affected by the 
frontotemporal syndrome (executive and language functions, fluency and behaviour), but 
assesses also memory and visuospatial functions.  
Objectives:  
A. To investigate the relationship between the ECAS and the Addenbrooke’s Cognitive 
Examination (ACE-III).  
B. To investigate the effects of age, education, and IQ on the ECAS and create appropriate cut-
off scores to determine abnormality. 
Methods: 
A: 57 healthy participants (aged 35-80) were assessed with the ECAS, the Wechsler 
Abbreviated Scale of Intelligence (WASI-II), and the ACE-III.  
B: 80 healthy participants (aged 51-80) were divided into four groups according to age and 
education and were tested with the ECAS and the WASI-II.  
Results: 
The ECAS and the ACE-III have a good convergent validity with a significant correlation. 
Regression analysis revealed that IQ, followed by age, were the strongest predictors of the total 
ECAS score. IQ predicted 24% of the ECAS and 46% of the ACE-III variance. Education was 
not a significant predictor over and above IQ for both the ECAS and the ACE-III. Abnormality 
cut-off scores adjusted for age and education are presented. 
Conclusions: 
The ECAS shows good convergent validity with the ACE-III, but is less influenced by 
intelligence and presents less ceiling effects. The inclusion of an executive function assessment 
and behavioural interview in the ECAS makes it particularly useful for the assessment of 
frontal lobe disorders. 
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Introduction 
 
The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was developed to assess the 
cognitive and behavioural changes associated with ALS (1) since a significant percentage of 
these patients develop a fronto-temporal degenerative syndrome (2,3). The neuropsychological 
profile of ALS is somewhat heterogeneous and previous existent cognitive screening tests did 
not assess the full range of cognitive and behaviour change present in ALS, and most were not 
suitable for patients with physical disability. The ECAS has proven to be sensitive to detect the 
changes in executive functions, fluency, and language in patients with ALS; in addition, it was 
designed to differentiate these changes from those found in other pathologies, including 
Alzheimer’s disease (1). It has also been validated against extensive neuropsychology showing 
high sensitivity and specificity (4,5) and against other screening tests including the Frontal 
Assessment Battery (FAB), Montreal Cognitive Assessment (MoCA) and Consortium to 
Establish a Registry for Alzheimer’s Disease plus Scale (CERAD plus) (6,7).  
 
The Addenbrooke’s Cognitive Examination (ACE-III) is a widely used dementia screening test 
in the UK (8). It is proven to have very good diagnostic accuracy for patients with memory 
complaints (9); with greater accuracy than the Montreal Cognitive Assessment (MoCA), the 
Mini-Mental State Examination and the Memory Impairment Screen (10). We chose the ACE-
III to compare against the ECAS over other screening tests, because it is one of the most 
commonly used cognitive tests in the UK and beyond to diagnose dementia. It has been 
validated in a number of patient groups (11,12,13). Furthermore, both the ACE-III and ECAS 
are multidomain and have similar assessment times (14, 15, 16). Although designed for the 
detection of different types of dementia, its sensitivity to detecting frontotemporal dementia 
and in particular the behavioural variant (bvFTD) is inconsistent (17,18,19). Hsieh et al. (20) 
showed that patients with bvFTD displayed a cognitive profile consisting of deficits in verbal 
memory, attention, fluency and language using the ACE-III. However, apart from verbal 
fluency, the ACE-III does not include an assessment of executive functions, the most 
prominent cognitive deficit in this type of dementia. Furthermore, the sensitivity and specificity 
of the given cut-off scores are for a general diagnosis of dementia that comprises Alzheimer’s 
Disease, bvFTD and Primary Progressive Aphasia. They propose that fronto-temporal 
dementia should be confirmed with specific functional and behavioural inventories such as the 
Cambridge Behavioural Inventory, the Neuropsychiatric Inventory or the Frontotemporal 
Dementia Rating Scale FRS (FTDFRS).  Given the inclusion of tests of executive functions 
and an informant interview to detect abnormal behaviours, based on the most recent diagnostic 
criteria for bvFTD (21), the ECAS may be a more suitable test to assess this type of dementia.   
 
The effect of demographic factors including age and education has been explored using local 
and/or translated versions in German, Italian, Chinese and Irish (6,7,5,22,23) but not in a 
British population. Age has been found to significantly correlate with total ECAS scores in 
most studies (6,7,5,22), with the exception of one (23). Although education was shown to 
correlate with ECAS scores across studies, the relation to measures of IQ has not been explored. 
Given the correlation between age and education found in the German, Italian and Irish studies, 
age and education adjusted local normative data have been produced.    
 
This study had two primary aims: 
• Objective 1: Investigate the relationship between the ECAS and Addenbrooke’s 
Cognitive Examination (ACE-III). 
• Objective 2:  Investigate the effect of age, education, and IQ on the ECAS in a 
healthy population to create appropriate adjusted cut-off scores to detect abnormality. 
Method 
 
A.  Relationship between the ECAS and the ACE-III 
 
Participants 
Healthy individuals (n=57) between the ages of 35 to 80 years old were recruited from the local 
population and the Psychology Volunteer Panel of the University of Edinburgh. Participants 
did not have any neurological illness in their medical history, or current psychiatric illness, or 
any learning disabilities. All were native English speakers. 
A minimum of 55 participants was decided for this study, in order to predict a medium effect 
size ( 𝑓𝑓2= 0.15) (24), with an alpha of 0.05 and a power of 0.80 in a linear regression of one 
predictor (25). A sample size of 55 is also adequate for predicting a large effect size (p= 0.5), 
with an alpha of 0.05 and a power of 0.80 in a correlation (minimum sample size would have 
been of 21). Both calculations were done using G*Power (26). 
 
 
Materials 
The Edinburgh Cognitive and Behavioural ALS Screen (ECAS). The ECAS is a short 
screening test (15-20 min) created to assess symptoms associated with cognitive and or 
behavioural impairment present in ALS. The ECAS is multidomain, providing subscores for 
language, fluency, executive, memory and visuospatial abilities. Language is evaluated by 
naming, comprehension and spelling. Fluency is measured by a free production of words 
beginning with the letter ‘s’ and a restrained production of words beginning with the letter ‘t’ 
but with only four letters. Executive functions are measured by a reverse digit span, alternation 
of letters and numbers, inhibitory sentence completion, and social cognition. Memory includes 
measurements of immediate recall, delayed percentage retention and delayed recognition. 
Visuospatial abilities are measured with dot and cube counting, and number location. The 
ECAS also includes a behaviour interview based on diagnostic criteria for bvFTD that is 
undertaken with an informant/carer (1, see http://ecas.psy.ed.ac.uk ).  
 
Addenbrooke’s Cognitive Examination (ACE-III). The ACE-III is a commonly used 
screening test for dementia. It assesses the abilities of attention, memory, fluency, language 
and visuospatial functions (27).  
 
Wechsler Abbreviated Scale of Intelligence (WASI-II). The WASI-II is the brief version of 
the Wechsler Adult Intelligence Scale. We used the 15 minutes version with 2 subtests to obtain 
a measure of intelligence (Vocabulary and Matrix Reasoning) (28).  
 
 
B.  The Effect of Age and IQ on the ECAS  
 
Participants 
A total of 80 participants undertook this study. Thirty-three participants from the first study 
were included; and an additional 47 healthy individuals between the ages of 51 to 80, 
recruited from the local population and the Psychology Volunteer Panel of the University of 
Edinburgh. Participants did not have any neurological illness in their medical history, or 
current psychiatric illness, or learning disabilities. All were native English speakers. Social 
economical status was obtained based on the occupation of the participants. The classification 
was done according to the Standard Occupational Classification proposed by the Office for 
National Statistics (29). 
 Participants were divided into 4 groups according to their age and education. Age: 51-65 years 
old and 66-80 years old, these age ranges were chosen to parallel typically used division for 
early versus late onset dementia. Education: secondary school or a technical degree vs 
university degree, or postgraduate degree. A minimum of 19 participants per group was 
decided in order to predict a large effect size (f= 0.40) (24), this number of participants was 
obtained using an alpha of 0.05 and a power of 0.80 (25) for a one-way ANOVA using 
G*Power (26), we included in some of the groups 1 or 2 more participants in case we needed 
to exclude some outliers.   
 
Ethical Approval 
This study was approved by The Psychology Research Ethics Committee of the University of 
Edinburgh. 
 
Statistical Analysis 
The data were analysed using SPSS statistics version 22. Pearson’s correlations were used to 
assess the relationship between variables. ANOVA and t Tests were undertaken on parametric 
data to assess the difference between groups. ANOVA stepwise linear regression was used to 
find the variables that predicted the final score of the ECAS. ANOVA linear regressions were 
done to find the effect of IQ on the ECAS and the ACE-III.  
 
 
 
 
 
Results 
 
A.  Relationship between ECAS and ACE-III 
 
The sample had 34 males and 23 females with a mean age of 56 years (±13.29, 35-80). The 
age of when they finished education was of 19.22 years (±3.20, 14-26), and their mean IQ was 
of 111.23 (±16.73, 75-156). Performance of participants on the ECAS and the ACE-III is 
presented in Table 1. The total scores of the ACE-III and the ECAS were significantly and 
moderately correlated (r = .538, p < 0.001). Memory (r = .368, p = 0.005), Fluency (r = .503, 
p < 0.001) and Language (r = .411, p = 0.002) correlated significantly between screens, 
however Visuospatial abilities (r = .197, p < 0.141) did not correlate between both tests.  
 
As can be seen in Figure 1 the ACE-III suffered from more ceiling effects than the ECAS with 
some participants achieving full marks for the ACE-III, whereas none reached the maximum 
score for the ECAS. ANOVA linear regression models showed that 24% of the variance of the 
total score of the ECAS (F(1,54)=17.292, p< .001) was predicted by IQ (β=.492, t=4.15, 
p<.001), whereas 46% of the variance of the total score of the ACE-III (F(1,54)=46.187, p< 
.001) was predicted by IQ (β=.679, t=6.79, p<.001).  
 
Overall, the scores of the domains of the ACE-III were more dependent on IQ than the domains 
in the ECAS. The percentage of the variance explained by IQ was higher in the ACE-III for 
the domains of Memory (29% vs 22%) and Visuospatial (7% vs 2%). Language was the same 
for both tests (30%). Fluency was more dependent on IQ for the ECAS (12% vs 21%). The 
percentage of the variance explained by IQ was 16% for Attention on the ACE-III and 9% for 
the Executive domain on the ECAS.  
 B.  The effect of age, education and IQ. 
 
Demographics of the full sample are presented in Table 2. There were no significant differences 
regarding IQ (F(1,78)=.681, p=.412) nor in socioeconomic status (F(1,78)=1.084, p=.301). 
Three outliers (more than 2 standard deviations from the mean) in the ECAS total score were 
removed from the data in the further analyses. The remaining sample presents scores from 97 
to 134 on the total score of the ECAS.  
 
An ANOVA stepwise linear regression model was undertaken including the variables of 
gender, age, education, and IQ. The most significant model predicted 32.5% of the variance of 
the ECAS Total Score (F(3,73)=11.736, p< .001). This model included the variables of IQ 
(β=.557, t=5.54, p<.001), age (β=-2.82, t=-2.81, p=.006) and gender (β=.197, t=2.04, p=.045).  
Education was not significant in the model since it could be sufficiently explained by IQ (r = 
.514, p < 0.001). Women scored slightly higher on the total score of the ECAS (119.16) in 
comparison to men (116.21). 
 
Abnormality Cut-off scores  
Education and age adjusted cut offs for abnormality are presented based on Education (those 
with and without a university degree) and age (below and above 65). Abnormality cut-offs 
were based on the 5 percentile (Table 3).  Education was chosen over IQ to create the cut-off 
scores for the ease of use in association with the ECAS within the MND clinical services, since 
it is more easily available to than IQ.  
  
 
Discussion 
 
This study demonstrated that the ECAS has a good convergent validity with a commonly used 
dementia screening test, the ACE-III. A comparison of performance on the two assessments 
revealed that the ECAS has less ceiling effects overall in comparison with the ACE-III, since 
not one of the healthy participants scored full marks on the ECAS. Performance on the ECAS 
also seems to be less influenced by intelligence levels in comparison with the ACE-III, as IQ 
predicted 24% of the variance of the ECAS against 46% in the ACE-III. Visuospatial scores 
were more dependent on IQ in the ACE-III (7% as compared with the ECAS 2%) which is 
most likely related to the drawing component of the cube and the clock tasks. Fluency was 
more dependent on IQ in the ECAS (21%) as compared with the ACE-III (12%) which may be 
related to the inclusion of a constrained fluency in the ECAS and the more demanding lexical 
search for 4 letter words.  Overall, IQ predicted more variance in the ACE-III over the ECAS 
which is most likely related to the different demands of the tests. The ACE-III includes the 
drawing figures such as a cube, the repetition of complex words and phrases and the inclusion 
of general knowledge questions. It is likely that some if not all of these components may be 
performed better in people with higher IQ. 
 
All domains of the ECAS correlated with their counterparts in the ACE-III apart from 
visuospatial functions. The lack of correlation between the measurements of visuospatial 
abilities may be related to different methods used to assess these functions in the two tests. The 
ECAS was created for people with physical disability, and therefore does not include drawing, 
which is required for the ACE-III. For patients with motor dysfunction impairment on the 
visual task in the ACE-III could be due to motor problems (weakness, dyspraxia or rigidity, 
interfering with the quality of drawing), while the ECAS reflects visuospatial functions 
independently of motor skills. A more in depth comparison of the ECAS and ACE-III in 
measuring the cognitive decline with patients of different dementias, in particular Alzheimer’s 
Disease and Frontotemporal Dementia, is needed to evaluate the utility of these tests in 
diagnosing and assessing change of the different pathologies. The ECAS may also be applied 
as a useful cognitive screening tool in other neurological disorders characterised by motor as 
well as cognitive dysfunction, such as Progressive Supranuclear Palsy (30) or Corticobasal 
Degeneration (31) 
 
The average IQ of some of our groups was higher than what you would expect in a normal 
population, which may be a limitation of the study. However, the literature indicates that when 
a sample comes from volunteers rather than randomly selected, the subjects tend to be healthier, 
have completed more years of education and have higher cognitive abilities (32, 33, 34, 35). 
We attempted to control for this during the recruitment process, by recruiting through churches, 
sport centres and outside schools; and successfully controlled for years of education. It is of 
note that most studies which validate dementia screening tests, do not measure IQ but rely on 
education level as a group descriptor, and it is therefore likely that the samples used in these 
studies would have a higher IQ than average, similar to our study, since it is a characteristic of 
the volunteer sample. 
 
IQ, age and gender were significant predictors of the total score of the ECAS. The correlation 
of the ECAS with age has been found previously in the German-Swiss versions of the ECAS 
(6,22), the Italian version (7), and the Irish version (5). Education was not a significant 
predictor of the ECAS when IQ was included in the model because of their strong correlation. 
The influence of IQ on the ECAS has not been measured previously. Somewhat surprisingly 
in our sample, gender was also a significant predictor of performance on the ECAS, although 
much weaker than age and IQ. Gender was not reported to significantly affect ECAS 
performance in two previous studies (7,23). In our study, women performed slightly better than 
men on ECAS Total Score. Within the ECAS domains, this effect was most pronounced in the 
Executive functions predicting 3% of the variance of the score but this difference did not reach 
significance.  
 
Overall the cut-off scores for abnormality suggested from these findings were similar to those 
originally proposed (1), but nevertheless, may help to discern the impairment in cases where 
the score falls in the borderline range (4). In such situations, age and education can be taken 
into account; for example a score of 105 on the ECAS would not signify an impairment for 
someone in their 70’s and without a university degree, whereas the same score would indicate 
a possible impairment for someone in their 50’s with a university degree.  
 
It is noted that our sample did not include people younger than 51 nor older than 80. People 
under 50 with a diagnosis of dementia represent 0.35% of the dementia population in Scotland 
(36), and it is advised in these cases that the same cut-off as 51-65 could be used. Future studies 
could look at creating separate cut-off scores for those over the age of 80, as they represent a 
larger percentage of the population with dementia (36). 
 
Conclusion 
 
The ECAS shows good convergent validity with the ACE-III, but is less influenced by 
intelligence and presents less ceiling effects in comparison to the ACE-III. Therefore, the 
ECAS is a suitable screening tool in particular in those: where cognitive assessment is 
complicated by the presence of motor symptoms; with executive dysfunction symptoms; and 
those highly educated high-performers with mild cognitive impairment or early dementia. The 
inclusion of both assessments of executive functions and behaviour makes the ECAS an 
appropriate choice for the assessment of frontal lobes disorders. 
 
Acknowledgements 
 
Mónica De Icaza Valenzuela was funded by a studentship from the Mexican National Council 
of Science and Technology (CONACYT). This study was funded by the University of 
Edinburgh. The authors thank all the participants in this research.  
 
Declaration of interest 
 
The authors have no known conflict of interest in relation to the publication of this paper.  
 
 
 
 
 
 
 
 
 
 
 
 
References 
1. Abrahams, S., Newton, J., Niven, E., Foley, J., and Bak, T, (2014). Screening for 
cognition and behaviour changes in ALS. Amyotrophic Lateral Sclerosis and 
Frontotemporal Degeneration. 15 (1-2): 9-14 
2. Goldstein, L.H. and Abrahams, S. (2013) Changes in cognition and behaviour in 
amyotrophic lateral sclerosis: nature of impairment and implications for assessment. 
Lancet Neurol, 12, 368-380 
3. Strong, M., Abrahams, S., Goldstein, L., Woolley, S., Mclaughlin, P., Snowden, J. et 
al. (2017) Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-
FTSD): Revised diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontemporal 
Degeneration. 18, (3-4), 153-174  
4. Niven, E., Newton, J., Foley, J., Colville, S., Swingler, R., Chandran, S. et al. (2015) 
Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis 
Screen (ECAS): A cognitive tool for motor disorders. Amyotrophic Lateral Sclerosis 
and Frontotemporal Degeneration. 16 (3-4): 172-179 
5. Pinto-Grau, M., Burke, T., Lonergan, K., McHugh, C., Mays, I., Madden, C. et al. 
(2017) Screening for cognitive dysfunction in ALS: validation of the Edinburgh 
Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted 
normative data. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18 
(1-2) 99-106 
6. Lulé, D., Burkhardt, C., Abdulla, S., Böhm, S., Kollewe, K., Uttner, I. et al. (2015) The 
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: A cross-
sectional comparison of established screening tools in a German-Swiss population. 
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. 16 (1-2): 16-23 
7. Poletti, B., Solca, F., Carelli, L., Madotto, F., Lafronza, A., Faini, A. et al. (2016) The 
validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). 
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 17, (7-8): 489-498 
8. Jeyapaul, P. and Kerwick, S. (2008) Addenbrooke’s Cognitive Examination as a better 
discriminator of cognitive impairment than the Mini-mental State Examination in 
patients with dementia. International Psychogeriatrics. 20, (3) 642-643  
9. Jubb, M. and Evans, J. (2015) An Investigation of the Utility of the Addenbrooke’s 
Cognitive Examination III in the Early Detection of Dementia in Memory Clinic 
Patients Aged over 75 years. Dementia and Geriatric Cognitive Disorders. 40, (3-4), 
222-232 
10. Matías-Guiu, J.A., Valles-Salgado, M., Rognoni, T., Hamre-Gil, F., Moreno-Ramos, 
T., and Matías-Guiu, J. (2017) Comparative Diagnostic Accuracy of the ACE-III, MIS, 
MMSE, MoCA, and RUDAS for Screening of Alzheimer Disease. Dementia and 
Geriatric Cognitive Disorders. 43, (5-6), 237-246 
11. Lees, R.A., Hendry BA, K., Broomfield, N., Stott, D., Larner, A.J. and Quinn, T.  
(2017) Cognitive assessment in stroke: feasibility and test properties using differing 
approaches to scoring of incomplete items. International Journal of Geriatric 
Psychiatry, 32 (10), 1072-1078 
12. Davies, R., Dawson, K., Mioshi, E., Erzinçlioǧlu, S., and Hodges, J.R. (2008) 
Differentiation of semantic dementia and Alzheimer’s disease using the 
Addenbrooke’s Cognitive Examination (ACE). International Journal of Geriatric 
Psychiatry, 23 (4), 370-375 
13. McColgan, P., Evans, J.R., Breen, D.P., Mason, S.L., Barker, R.A., and Williams-
Gray, C.H. (2012) Addenbrooke’s Cognitive Examination-Revised for mild cognitive 
impairment in Parkinson’s disease. Movement Disorders, 27(9), 1172-1176  
14. Velayudhan, L., Ryu, S., Raczek, M., Philpot, M., Lindesay, J. et al. (2014) Review of 
brief cognitive tests for patients with suspected dementia. International 
Psychogeriatrics. 24 (8), 1247-1262 
15. Newman, C.G.J., Bevins, A.D., Zajicek, J.P., Hodges, J.R., Vuillermoz, E. et al. (2018) 
Improving the quality of cognitive screening assessments: ACEmobile, and iPad-based 
version of the Addenbrooke’s Cognitive Examination-III. Alzheimers Dement (Amst). 
10, 182-187 
16. Morris, R.G., and Brookes, R.L. (2013) Neuropsychological Assessment of Older 
Adults. In L.H. Goldstein and J.E. McNeil (Eds.) Clinical Neuropsychology: A 
Practical Guide to Assessment and Management for Clinicians, Second Edition (pp. 
347-373), Chichester, West Sussex: John Wiley & Sons 
17. Yoshida, H., Terada, S., Honda, H., Ata, T., Takeda, N., Kishimoto, Y. et al. (2011) 
Validation of Addenbrooke’s cognitive examination for detecting early dementia in a 
Japanese population. Psychiatry Research. 185, 211-214 
18. Bier, J.C., Ventura, M., Donckels, V., Van Eyll, E., Claes, T., Slama, H. et al. (2004) 
Is the Addenbrooke’s Cognitive Examination effective to detect frontotemporal 
dementia? Journal of Neurology, 251, 428-431 
19. Elamin, M., Holloway, G., Bak, T.H. and Pal, S. (2015) The Utility of the 
Addenbrooke’s Cognitive Examination Version Three in Early-Onset Dementia. 
Dementia and Geriatric Cognitive Disorders. 41, (1-2), 9-15 
20. Hsieh, S., Schubert, S., Hoon, C., Mioshi, E. and Hodges, J.R. (2013) Validation of the 
Addenbrooke’s Cognitive Examination III in Frontotemporal Dementia and 
Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 36, 242-250 
21. Rascovsky, K., Hodges, J.R., Knopman, D., Mendez, M.F., Kramer, J.H., Neuhaus, J. 
et al. (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of 
frontotemporal dementia. Brain. 134 (pt9): 2456-77 
22. Loose, M., Burkhardt, C., Aho-Özhan, H., Keller, J., Abdulla, S., Böhm, S. et al. 
(2016) Age and education-matched cut-off scores for the revised German/Swiss-
German version of ECAS. Amyotrophic Lateral Sclerosis and Frontotemporal 
Dementia. 17, (5-6): 374-376 
23. Ye, S., Ji, Y., Li, C., He, J., Liu, X. and Fan, D. (2016) The Edinburgh Cognitive and 
Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population. Plos 
One. 11(5): e0155496 
24. Cohen, J. (1988) Statistical Power Analysis for the Behavioural Sciences. Hillside, 
N.J.; Hove: Lawrence Erlbaum, pp. 287, 478   
25. Field, A. (2009) Discovering Statistics using SPSS, 3rd edn, London, UK:SAGE, pp. 
69, 115 
26. Faul, F.,  Erdfelder, E., Lang, A.G., and Buchner, A. (2007). G*Power 3: A flexible 
statistical power analysis program for the social, behaviour, and biomedical sciences. 
Behavior Research Methods, 39, 175-191 
27. Noone, P. (2015) The Addenbroke’s Cognitive Examination-III. Occupational 
Medicine. 65, (5): 418-420 
28. Wechsler, D. (2011) Wechsler Abbreviated Scale of Intelligence – Second Edition. San 
Antonio, Texas: Pearson. 
29. Office for National Statistics (2010) SOC2010 volume 3: the National Statistics Socio-
economic classification (NS-SEC rebased on SOC2010) 
http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/o
ns/guide-method/classifications/current-standard-classifications/soc2010/soc2010-
volume-3-ns-sec--rebased-on-soc2010--user-manual/index.html 
30. Colosimo, C., Bak, T.H., Bologna, M., and Berardelli, A. (2014) Fifty years of 
progressive supranuclear palsy. Journal of Neurology, Neurosurgery & Psychiatry, 85 
(8), 938-944  
31. Bak, T.H., Hodges, J.R. (2008) Corticobasal Degeneration: clinical aspects in 
Duyckaerts, C. & Litvan, I., (eds) Handbook of Clinical Neurology: Dementias, 509-
521  
32. Ganguli, M., Lytle, M. E., Reynolds, M. D., and Dodge, H.H. (1998) Random Versus 
Volunteer Selection for a Community-Based Study, Journal of Gerontology: 
MEDICAL SCIENCES, 53A, 1, M39-M46 
33. Henrich, J., Heine, S. J., and Norenzayan, A. (2010) The weirdest people in the world? 
Behavioral and Brain Sciences, 33, 61-135 
34. Arnett, B., and Rikli, R. (1981) Effects of Method of Subject Selection (Volunteer vs 
Random) and Treatment Variable on Motor Performance, Research Quarterly for 
Exercise and Sport, 52:4, 433-440 
35. Wrights, A.P., Fain, C.W., Miller, M.E., Rejeski, W.J., Williamson, J.D., and Marsh, 
A.P. (2015) Assessing physical and cognitive function of older adults in continuing 
care retirement communities: Who are we recruiting? Contemporary Clinical Trials. 
40, 159-165 
36. Prince, M., Knapp, M., Guerchet, M., McCrone, M., Prina, P. et al. (2014) Dementia 
UK: Update Second Edition report produced by King’s College London and the 
London School of Economic for the Alzheimer’s Society, p. 61  
 
 
Tables and Figures  
Table 1: Performance on the ECAS and ACE-III: 
N=57                      (max) Mean (SD) Median (range) 
ECAS total                136 115.87 (±11.30) 118      (88-134) 
ECAS language             28 26.71 (±1.81) 27          (20-28) 
ECAS fluency              24 19.40 (±3.46) 20          (10-24) 
ECAS executive            48 39.71 (±4.69) 40          (22-47) 
ECAS memory              24 19.22 (±3.57) 20            (7-24) 
ECAS visuospatial        12 11.59 (±0.90) 12            (7-12) 
ACE-III total               100 93.07 (±4.81) 94         (80-100) 
ACE-III attention          18 17.01 (±1.10) 17          (13-18) 
ACE-III memory          26 23.10 (±2.93) 24          (15-26) 
ACE-III fluency           14 12.59 (±1.29) 13            (9-14) 
ACE-III language         26 25.33 (±0.87) 26          (23-26) 
ACE-III visuospatial     16 15.01 (±1.14) 15          (11-16) 
Standard Deviation (SD), Edinburgh Cognitive and Behavioural ALS Screen (ECAS), 
Addenbrooke’s Cognitive Examination (ACE-III). Maximum score (max) 
 
 
 
 
 
 
 
Table 2: Demographics of The effect of age, education and IQ. 
Age 
group 
Education 
group  
Participants Age  
 
Age at finishing 
education 
IQ 
51-65 1 20 total 
(10 m) 
58.3  
(±4.64) 
52-65 
17.35  
(±2.08) 
15-24 
108.30  
(±14.56) 
75-139 
 2 21 total 
(11 m)  
59.23 
(±3.72) 
51-65 
22.52  
(±1.36) 
21-26 
128.38  
(±11.34) 
103-156 
66-80 1 19 total 
(9 m) 
73.00 
(±3.38) 
67-78 
16.94 
(±1.95) 
14-22 
115.26 
(±15.24) 
87-141 
 2 20 total 
(10 m)  
72.20 
(±4.00) 
67-80 
22.45 
(±1.73) 
19-26 
127.25 
(±10.12) 
111-142 
Education was divided between participants without a university degree (1) and participants 
with a university degree (2).  m (presumably males). Results are presented Mean (Standard 
Deviation) Range. 
 
 
 
 
 
 
 
Table 3: ECAS Age and Education adjusted cut-off scores to determine abnormality for 
ECAS Total Scores. 
Age Education Mean (SD) Range Cut-off 
≤65 1 119.650 (±8.628) 100-134 100 
 2 123.381 (±7.221) 110-133 110 
>65 1 117.000 (±8.062) 98-129 98 
 2 120.895 (±6.315) 108-131 108 
Education was divided between participants without a university degree (1) and participants 
with a university degree (2). Standard Deviation (SD) 
 
Figure 1 Distribution of scores on the (left) ECAS and (right) ACE-III. 
 
Edinburgh Cognitive and Behavioural ALS Screen (ECAS) mean 115.88 (±11.303), 
Addenbrooke’s Cognitive Examination (ACE-III) mean 93.07 (±4.81). 
 
 
